APA (7th ed.) Citation

F, L., A, P., M, D., G, F., G, S., & G, F. (2011). Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. BMC cancer, 11, 214. https://doi.org/10.1186/1471-2407-11-214

Chicago Style (17th ed.) Citation

F, Legge, Paglia A, D'Asta M, Fuoco G, Scambia G, and Ferrandina G. "Phase II Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients." BMC Cancer 11 (2011): 214. https://doi.org/10.1186/1471-2407-11-214.

MLA (9th ed.) Citation

F, Legge, et al. "Phase II Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients." BMC Cancer, vol. 11, 2011, p. 214, https://doi.org/10.1186/1471-2407-11-214.